Disease landscape

Sars-CoV-2 Infection clinical trials

Get alerts when Sars-CoV-2 Infection trials change

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-23

What changed in the last 30 days

4 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 2 with minor changes only.

Notable

COPE-VA · Outcomes and Pharmacotherapy Effectiveness in the VA Health Care System (COPE-VA)

Primary completion pushed from Sep 30, 2026 to Sep 30, 2027

VA Office of Research and DevelopmentNot specified NCT06160128 Registry history of NCT06160128 on ClinicalTrials.gov (opens the registry)

Sep 30, 2026
Notable

Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI

Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027

NYU Langone HealthNot specified NCT05615415 Registry history of NCT05615415 on ClinicalTrials.gov (opens the registry)

Sep 30, 2026

Show 2 trials with minor changes only

Minor

COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

Trial completed

Also in this update: Primary completion date changed from estimate of Jul 31, 2026 to Sep 22, 2026

BioNTech SEPhase 3 NCT07300839 Registry history of NCT07300839 on ClinicalTrials.gov (opens the registry)

Oct 16, 2026
Minor

Called Ibuzatrelvir in Adult and Adolescent · COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease

Trial sites expanded: 253 → 256 locations

PfizerPhase 3 NCT06679140 Registry history of NCT06679140 on ClinicalTrials.gov (opens the registry)

Oct 15, 2026

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1		4
Phase 1/2		2
Phase 2/3		1
Phase 3		2
Phase 4		1

Not charted: 35 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Top sponsors by active trials in this area

CorDx, Inc. (2) · NYU Langone Health (2) · Pfizer (2) · VA Office of Research and Development (2) · Boston University (1) · Centre Hospitalier Universitaire de Nice (1) · Centre Hospitalier Universitaire de Nīmes (1) · Children's National Research Institute (1) · Family Health Centers of San Diego (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1)

Get alerts when Sars-CoV-2 Infection trials change

Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.

Start monitoring free